Cognitive adverse events in patients with lung cancer treated with checkpoint inhibitor monotherapy: a propensity score-matched analysis

BACKGROUND: Cancer-related cognitive decline is a serious problem in long-term survival but no pivotal study has investigated whether checkpoint inhibitors (ICI) may be associated with cognitive adverse events. METHODS: This propensity score-matched analysis recruited non-small cell lung cancer (NSC...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Yifei, Liu, Nianqi, Wang, Yanqi, Zhang, Ao, Zhu, Zirui, Zhang, Zhiying, Li, Yiming, Jian, Guangmin, Fu, Guangzhen, Dong, Mingming, Zheng, Guoxing, Zhu, Pengfei, Zhong, Guanqing, Bai, Shenrui, Chen, Shuqin, Wei, Xiaolong, Tan, Jifan, Wang, Xinjia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154980/
https://www.ncbi.nlm.nih.gov/pubmed/37152366
http://dx.doi.org/10.1016/j.eclinm.2023.101987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154980/
https://www.ncbi.nlm.nih.gov/pubmed/37152366
http://dx.doi.org/10.1016/j.eclinm.2023.101987

Ejemplares similares